Core Viewpoint - Baicheng Pharmaceutical announced a related party transaction with Zhejiang Zhongshen Innovative Pharmaceutical Technology Co., Ltd. due to the connection with its former vice president, Feng Enguang, who is now a senior executive at Zhongshen [1] Group 1: Transaction Details - The company disclosed the signing of a supplementary agreement to the original technology development cooperation agreement, modifying the effective date to be contingent upon approval from the shareholders' meeting [1] - The original cooperation under the agreement has not yet commenced [1] Group 2: Regulatory Compliance - The transaction is classified as a related party transaction under the listing rules, requiring approval from the company's shareholders [1] - The company will submit the cooperation matter for review by the board and shareholders as per regulatory requirements [1]
百诚医药：关于BIOS-0629项目签署《技术开发合作协议》的补充公告